Journey Medical CORP (DERM) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

DERM ranks #5284 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

73 institutions disclose a position in DERM, but none treat it as a major bet — even Tang Capital Management LLC, its most concentrated holder, allocates just 0.5% of its own portfolio to it.

Salem Investment Counselors Inc has added to its DERM position for two straight quarters, increasing it by $174.5K to reach $241.6K today.

DERM is down 3.1% today, and institutions have been net sellers of $5.4M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

DERM reported a net loss of $6.1M over the trailing twelve months.

• Not yet profitable — net loss of $6.1M over the trailing twelve months
• Revenue grew 20.7% year over year
• Net income improved year over year, from -$8.7M to -$6.1M
• Operating cash flow was negative, using $12.4M in cash
• Current ratio of 1.79x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.97x equity — within a conventional range